Steroids in cystic fibrosis exacerbations: are we picking the right patients?
- 3 October 2024
- journal article
- letter
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 64 (4) , 2401225
Abstract
Shareable abstract Despite the infectious/inflammatory milieu of the CF lung, stratification by eosinophil count and targeted steroid therapy during exacerbation may also be preferential in people with CFhttps://bit.ly/3XrAk3bKeywords
This publication has 4 references indexed in Scilit:
- A randomised trial of oral prednisone for cystic fibrosis pulmonary exacerbation treatmentEuropean Respiratory Journal, 2024
- Blood eosinophil-guided oral prednisolone for COPD exacerbations in primary care in the UK (STARR2): a non-inferiority, multicentre, double-blind, placebo-controlled, randomised controlled trialThe Lancet Respiratory Medicine, 2023
- Eosinophil-guided corticosteroid therapy in patients admitted to hospital with COPD exacerbation (CORTICO-COP): a multicentre, randomised, controlled, open-label, non-inferiority trialThe Lancet Respiratory Medicine, 2019
- Blood Eosinophils to Direct Corticosteroid Treatment of Exacerbations of Chronic Obstructive Pulmonary Disease: A Randomized Placebo-Controlled TrialAmerican Journal of Respiratory and Critical Care Medicine, 2012